20 employees
Agilis Biotherapeutics designs and engineers DNA-based therapeutics for genetic disorders.
2013
$13M
from 1 investors over 1 rounds
Agilis Biotherapeutics Inc. raised $13M on February 24, 2017
Investors: Sands Capital Management